Wikinews articles are being copied to http://juiceenewsdaily, sometimes with attribution and sometimes without. en:User:Chiacomo has been communicating with the publisher of this site, attempting to encourage him to correctly attribute and otherwise follow the CC-by licensure. Today's article posting (http://www.juiceenewsdaily.com/index.php/2006/01/18/al-qaeda-bomb-maker-repo...) again failed to include either attribution or licensure.

After contacting Soufron, a member of the Wikimedia Foundation's legal team, for advice, I sent the following message to the publisher of juiceenewsdaily:

---- Hi! This is Amgine, and admin at Wikinews, a project of the Wikimedia Foundation.

I have spoken with our legal team regarding the use by juiceenewsdaily.com of the articles created on Wikinews. We really appreciate our articles being reused, which is why they are copyright but licensed under the terms of the Creative Commons Attribution license. Those terms may be found at http://creativecommons.org/licenses/by/2.5/legalcode (a synopsis is available at http://creativecommons.org/licenses/by/2.5/)

We have noticed your site, juiceenewsdaily.com, is not currently in compliance with this licensure, which requires that each article you choose to reuse must include a direct attribution ("This article from Wikinews" would suffice) and, as a redistributor, clearly stating the article is licensed under the CC-by and its terms (which may be satisfied by a link to the Creative Commons legal code, or a link back to the original article on Wikinews.)

We're sure this is merely an oversight on your part, and that you would not knowingly place your copyright statement on content which is legally copyrighted by others. We're also aware that it may take some time to correct this oversite, and are willing to allow 30 days for the content to be corrected or removed from juiceenewsdaily.com.

Wishing you the best,

Amgine http://en.wikinews.org/wiki/User:Amgine ----

Hopefully the letter will resolve the issue, but we'll be keeping an eye on the site in the meantime (WN articles accounted for more than half the articles on the site today.)

Amgine